Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Side effects of Tasigna may increase risk of heart attack, stroke, amputation and wrongful death.
A federal judge determined the lawsuit was not barred due to preemption laws, after plaintiff brought evidence suggesting Novartis had new information which could have led to updated label warnings.
Lawsuit claims Novartis purposefully hid risks of narrowing and hardening arteries to increase profits.